ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026
Mechanism of Cardiac Arrest in Fatal Anaphylaxis.
Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionAnaphylaxis is a short duration, potentially catastrophic allergic reaction where a rapid return to a person's baseline can be expected if vital organ function can be supported. Fatal anaphylaxis is a rare but potentially preventable cause of death at all ages. The three main mechanisms of rapid organ system failure leading to cardiac arrest in anaphylaxis are upper airway obstruction, lower respiratory obstruction principally from bronchospasm and cardiovascular failure. We aimed to measure the frequency and timing of each organ failure type leading to fatal anaphylaxis to further inform treatment recommendations.
methodsWe performed a population-based retrospective cohort analysis for the period 1 January 2003 to 31 December 2022 using Australian clinical data contained within the National Coronial Information System. The primary outcome was the primary organ that failed leading to initial physiological decompensation. Secondary objectives were to compare the time course of deterioration and complications between allergen groups. Multivariate logistic regression was used to quantify adjusted odds ratios between allergen categories for each of the three organ failure types.
resultsThere were 371 anaphylaxis deaths for the study period (mean age 55.7 years, male 58.5%) with the primary outcome recorded in 250 (67.4%). In overall all-cause anaphylaxis fatalities, the most common organ failure was bronchospasm-induced respiratory failure (n = 153, 61.2%). Cardiovascular failure was less common (n = 73, 29.2%) and upper airway obstruction occurred in 24 (9.6%). There were significant differences in the primary organ system failure according to allergen trigger categories. Fatal food anaphylaxis was exclusively associated with respiratory failure (bronchospasm 94.8%, upper airway 5.2%).
conclusionWe found that respiratory failure rather than cardiovascular failure was the most common cause of cardiorespiratory arrest in fatal anaphylaxis. Death from food-triggered anaphylaxis appears to be exclusively a primary respiratory event. International anaphylaxis guidelines require appropriate emphasis on respiratory symptoms and treatment to further reduce the risk of anaphylaxis fatalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.